International organizations

This archive collects milestones and solutions-focused stories involving international organizations — bodies such as the United Nations, World Health Organization, and regional alliances working across borders on global challenges. Read about the moments when coordinated international action produced measurable progress.

Cat and dog, for article on E.U. cat and dog welfare rules

E.U. adopts first-ever bloc-wide rules to protect cats and dogs from abuse

By / / Good News For Humankind

The European Parliament has passed the first-ever E.U.-wide rules protecting cats and dogs from abusive breeding, cruel trade practices, and exploitation. Approved by 558 votes to 35, the regulation mandates microchipping, bans inbreeding and harmful physical breeding, and closes a loophole that allowed animals to enter the bloc as pets and be sold commercially. It covers a pet industry worth €1.3 billion a year and affects hundreds of millions of animals across the bloc.\n\n*(80 words)*

Tunisian flag, for article on trachoma elimination

Tunisia eliminates trachoma as a public health problem

By / / Good News For Humankind

Trachoma is officially gone as a public health problem in Tunisia — a disease that once affected at least half the country’s population. The World Health Organization has now validated Tunisia as the 31st country to eliminate it, and the first neglected tropical disease ever crossed off the country’s list. The win came from decades of patient work: nationwide screening, eye care woven into schools and clinics, hygiene outreach, and steady improvements in water and sanitation. Around the world, roughly 1.9 million people still live with trachoma-related blindness or visual impairment, and 136 million remain at risk. Tunisia’s story is proof that preventable blindness doesn’t have to stay that way — and a hopeful nudge toward the WHO’s 2030 goal of ending trachoma everywhere.

Two sets of hand holding newborn baby, for article on Coartem Baby malaria treatment

W.H.O. approves world’s first malaria treatment for newborn babies

By / / Good News For Humankind

Newborn babies with malaria finally have a medicine made just for them. Coartem Baby, a cherry-flavored tablet that dissolves into breast milk or water, just earned World Health Organization prequalification — a green light that opens the door to public health systems across sub-Saharan Africa. For decades, doctors had to guess at doses using drugs built for older children, even as research showed infants were getting infected too. Ghana has already begun rolling it out, and Novartis has committed to what it calls “largely not-for-profit pricing” in malaria-endemic regions. Alongside new vaccines and better bed nets, it’s a quiet but meaningful sign that the fight against malaria — which still kills hundreds of thousands of children a year — is reaching the patients it had long overlooked.

Sunset by smokestacks, for article on fossil fuel phaseout

More than 50 nations attend world-first conference on phasing out fossil fuels

By / / Good News For Humankind

Fossil fuel phaseout talks just crossed a real threshold: for the first time, more than 50 nations sat down together specifically to plan a way off coal, oil, and gas. The two-day gathering in Santa Marta, Colombia, brought together an unusually wide mix — major producers like Australia, Norway, and Canada alongside Pacific island nations like Tuvalu and Vanuatu, with Europe and emerging economies in between. No binding deals were expected, but the recommendations will feed into a voluntary roadmap being shaped under Brazil’s COP30 leadership. It’s a small, hopeful shift: producers and consumers finally talking openly about a transition that, until recently, was almost taboo to name out loud.

African children smiling, for article on measles vaccination Africa

Nearly 20 million measles deaths averted in Africa since 2000

By / / Good News For Humankind

Measles vaccines in Africa have prevented an estimated 19.5 million deaths since 2000 — roughly 800,000 lives saved every year for nearly a quarter century. A new WHO and Gavi analysis credits steady investment in cold-chain systems, community health workers, and political will, with coverage for the critical second measles dose climbing more than tenfold over that stretch. This year, Cabo Verde, Mauritius, and Seychelles became the first sub-Saharan nations to officially eliminate measles and rubella, a milestone once considered out of reach. The story is a powerful reminder that global health progress, though uneven, compounds quietly over decades — and that protecting children anywhere strengthens the case for protecting them everywhere.

A snowy owl in flight over a winter landscape for an article about migratory species protection

132 nations extend UN protection to 40 migratory species at historic Brazil summit

By / / Good News For Humankind

Migratory species protection expanded significantly at CMS COP15, where 132 nations meeting in Campo Grande, Brazil voted to extend international legal safeguards to 40 new species, including the snowy owl, giant otter, striped hyena, and great hammerhead shark. The decision pushes the U.N. Convention on the Conservation of Migratory Species total past 1,200 protected species for the first time. The achievement carries urgent weight: a new U.N. report found 49% of species already covered by the treaty are still declining. Conservation priorities set at the summit will shape international wildlife policy through at least the next CMS conference in 2029.

A researcher examines lab samples under blue light for an article about HIV cure research — 12 words

Humanity ends the HIV/AIDS epidemic in landmark global achievement

By / / Archive of Human Genius

The HIV/AIDS epidemic could officially end by 2054, when UNAIDS projects new infections will fall below the global threshold for epidemic control. The path is already visible: long-acting injectables, community health workers, and generic drugs under $20 a year are reshaping care today. If it holds, it’s proof that sustained collective effort can unmake even the cruelest diseases.

A health worker filters drinking water in a rural African village for an article about guinea worm disease eradication

Guinea worm disease nears total eradication with just 10 human cases recorded

By / / Good News For Humankind

Guinea worm disease is on the verge of becoming only the second human disease ever eradicated, after confirmed cases fell to a historic low of just 10 worldwide. This ancient parasite, which has tormented humans for millennia, has been reduced by more than 99.9 percent since the 1980s through an extraordinary public health campaign relying entirely on community education, water filtration, and local surveillance — no vaccine or drug exists. The achievement, led largely by the Carter Center and local health workers across sub-Saharan Africa, demonstrates that sustained, community-driven effort can conquer even the oldest and most entrenched diseases.

A rural health worker examines a child's eye in bright sunlight for an article about trachoma elimination in Egypt

Egypt eliminates trachoma, ending millennia of preventable blindness

By / / Good News For Humankind

Egypt has eliminated trachoma as a public health problem, ending a bacterial eye disease that has blinded people in the Nile Valley for more than 3,000 years. The World Health Organization formally validated the achievement, making Egypt the 27th country to reach this milestone. Success came through two decades of coordinated effort combining surgery, antibiotics, hygiene education, and expanded rural sanitation infrastructure. The elimination is significant because Egypt’s scale — over 100 million people across complex rural geography — demonstrates that the WHO’s goal of global trachoma elimination by 2030 is achievable.

A young child receives a vaccine injection at a health clinic, for an article about malaria vaccine price cut in Africa

Malaria vaccine price cut will protect 7 million more children by 2030

By / / Good News For Humankind

Malaria vaccine price cut: a landmark deal between Gavi and UNICEF has reduced the cost of the R21/Matrix-M malaria vaccine by roughly 25%, dropping the price to under per dose. The savings unlock more than 30 million additional doses, extending protection to an estimated 7 million more children across 24 African countries by 2030. The agreement integrates R21 into routine immunization programs, making it part of standard care rather than a one-off campaign. In a region where malaria kills a child every two minutes, this financing breakthrough offers a replicable model for expanding access to lifesaving vaccines worldwide.